Article Sidebar
Views PDF: 436
Treatment adherence in asthma outpatients at Ba Ria hospital in 2021-2022
Main Article Content
Abstract
Background: The Global Burden of Disease Study found that in 2017, asthma caused about 495 thousand deaths, affecting about 300 million people worldwide. Adherence increases the effectiveness of treatment. Studies on asthma in the world and in Vietnam show that the adherence rate fluctuates in various regions, ranging from 30 to 70%. Objectives: To determine the rate of treatment adherence and some associated factors in outpatients with asthma at Ba Ria Hospital in 2021-2022. Materials and methods: A cross-sectional study on 247 asthma patients from October 2021 to January 2022. Assessment of treatment adherence using Atta Abbas Naqvi's General Medication Adherence Scale (GMAS) scale. Results: The study showed that 77.7% of asthmatics had adherence with GMAS 30-33 points (GMAS=33 accounted for 48.6%, GMAS=30-32 points accounted for 29.1%). Multivariable logistic regression analysis showed that age, smoking, Covid- 19 epidemic statistically significantly affect treatment adherence of asthma patients. Conclusion: The study showed that treatment adherence in asthma outpatients at the hospital reached a high level compared with domestic and international studies.
Article Details
Keywords
Adherence, asthma, GMAS, associated factors
References
2. Bộ Y tế (2021), Quyết định 5850/QĐ-BYT ngày 24/12/2021 về việc ban hành tài liệu chuyên môn “Quy trình lâm sàng chẩn đoán và điều trị hen phế quản ở người lớn và trẻ em ≥ 12 tuổi”.
3. Global Intitative for Asthma (GINA) (2020), Sổ tay hướng dẫn xử lý và dự phòng hen phế quản (dùng cho người lớn và trẻ em trên 5 tuổi) (dành cho cán bộ y tế), người dịch: Lê Thị Tuyết Lan, Hội nghị Khoa học thường niên-Hội Hen-Dị ứng-Miễn dịch lâm sàng thành phố Hồ Chí Minh.
4. Trần Thị Lý, Lê Văn Hợi, Đinh Ngọc Sỹ (2019), Thực trạng và hiệu quả sử dụng dịch vụ quản lý, chăm sóc người bệnh phổi tắc nghẽn mạn tính và hen ở một số đơn vị quản lý bệnh phổi mạn tính tại Việt Nam, Luận án tiến sĩ Y tế công cộng, Trường Đại học Y Hà Nội.
5. Cesar I Fernandez-Lazaro & Juan M García-González (2019), Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study, BMC family practice, 20 (1), pp.1-12.
6. GBD 2017 Causes of Death Collaborators (2018), Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017, The Lancet, 392 (10159), pp.1736-1788.
7. Mohd Isa, N. A., et al. (2020), Asthma control and asthma treatment adherence in primary care: results from the prospective, multicentre, non-interventional, observational cohort ASCOPE study in Malaysia, Med J Malaysia, 75 (4): 331-337. 8. Atta Abbas Naqvi, Mohamed Azmi Hassali et al. (2018), Development and validation of a novel General Medication Adherence Scale (GMAS) for chronic illness patients in Pakistan, Frontiers
in Pharmacology, 9, pp.1124.
9. Atta Abbas Naqvi, Mohamed Azmi Hassali et al. (2019), Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses,
Journal of drug assessment, 8 (1), pp.36-42.
10. Nguyen-Ho Lam , Nguyen-Thanh Nam, Le-Thuong Vu, Nguyen-Nhu Vinh, and Le-Thi Tuyet- Lan (2021), Stepping down therapy for well- controlled mild asthma: an experience from University Medical Center at Ho Chi Minh City, Asia Pac Allergy, 11 (1):e9 https://doi.org/10.5415/apallergy.2021.11.e9 pISSN 2233-8276·eISSN 2233-8268].
11. Plaza, V. , et al. (2021), Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records, J Investig Allergol Clin Immunol, 31(1): 58-64.
12. World Health Organization (2003), Adherence to long-term therapies : evidence for action/[edited by Eduardo Sabaté]. [cited 2021 21/02]; Available from: https://apps.who.int/iris/handle/10665/42682.